Oxalic Acid

Oxalic Acid

SCHEMBL8540602

Clc1ccc([C@H]2CCC[C@H]3CN(CC4CC4)C[C@H]32)cc1Cl.O=C(O)C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.39
CCR2 P41597 7/20 0.41
KCNH2 Q12809 6/20 0.41
KDM2B Q8NHM5 5/20 0.41
UTS2R Q9UKP6 4/20 0.40
TACR2 P21452 1/20 0.40
TACR1 P25103 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8540329 0.74 SLC6A3 (0.45) KCNH2SLC6A2SLC6A4SLC6A3
Fumaric Acid SCHEMBL8546918 0.72 GAA (0.38) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
Fumaric Acid SCHEMBL8547447 0.67 SLC6A3 (0.43) KCNH2SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL15751917 0.66 CCR5 (0.46) CCR2KCNH2TACR2TACR1
SCHEMBL15751590 0.66 CCR5 (0.46) CCR2KCNH2TACR2TACR1
SCHEMBL8545710 0.65 SLC6A2 (0.48) KCNH2SLC6A2SLC6A4SLC6A3CYP2D6
Hydrochloric Acid SCHEMBL8541267 0.64 SLC6A2 (0.47) KCNH2SLC6A2SLC6A4SLC6A3CYP2D6
Hydrochloric Acid SCHEMBL8541270 0.64 SLC6A2 (0.47) KCNH2SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL15751919 0.64 TACR1 (0.54) TACR2TACR1
SCHEMBL1421916 0.63 TACR1 (0.45) CCR2KCNH2TACR2TACR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690842-B1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMA CORP (US) 1998-12-16 EP disclosed
US-5508424-A REDUCED SIDE EFFECTS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-04-16 US disclosed